Previa Medical, a Lyon, France-based startup specialized in developing predictive medical devices, raised €2.1M in Seed funding.
Backers included Kreaxi, M2care, Veymont Participations, Hopla Memory, CCI Capital Croissance, Holding Seraip, Bpifrance and BNP Paribas.
Founded in 2020 and led by Quentin François, CEO, Previa Medical is a tech startup specialized in developing predictive medical devices that reduce the risk of complications in healthcare settings. The company is behind SEPSI-SCORE, a specialist AI-based solution designed to improve the early detection of sepsis. SEPSI-SCORE predicts a patient’s risk of developing sepsis by analyzing their health record and medical history in real time. The solution, which taps into a hospital’s existing software, can alert healthcare professionals to potential sepsis cases up to 48 hours before the first symptoms develop, meaning patients can be treated sooner, increasing their chances of survival.
The company intends to use the funds to run a prospective multicenter clinical trial for SEPSI-SCORE, aimed at scientifically validating the solution to achieve two objectives:
- Reducing inpatient length of stays
- Reducing the sepsis-mortality rate
The company also plans to strengthen its team, with a view to expanding its product’s reach and preparing for the commercial launch phase.
FinSMEs
16/02/2023